Prognos Health

New York, NY · Founded 2010 · Privately Held (backing)

Developer of a healthcare analytics platform designed to utilize patient-level data to derive clinical insights. Prognos Health is based in New York, NY and was founded in 2010. It has raised $66.5 million across 2 recorded rounds; the latest was a $23.3 million early-stage round in Apr 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$66.5M
Last round
Early Stage VC
Apr 2023
How much has Prognos Health raised?
$66.5Macross 2 recorded rounds · Nov 2017 – Apr 2023

Most recently, Prognos Health raised $23.3M in its Early Stage VC (Apr 2023).

Free account
More of Prognos Health with a free account
  • ·The complete investor list: 16 names
  • ·Watch Prognos Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Prognos Health round by round

2 rounds
Apr 2023Early Stage VC$23.3MSEC filing▮
10 investors participated
Nov 2017Early Stage VC$17.0MSEC filing▮
5 investors participated

How much has Prognos Health raised?

Prognos Health has raised $66.5 million in total; 2 of its rounds are on record. The largest on record was a $23.3 million early-stage round in Apr 2023.

Prognos Health has filed 3 Form Ds with the SEC since 2017, most recently in May 2023 ($23.3 million sold to 10 investors).

Prognos Health investors

16 investors are on record for Prognos Health, including Labcorp Venture Fund, MSD Global Health Innovation Fund, Marshall Wace and Montage Capital. By type, the record holds 4 venture capital firms and 1 hedge fund. The early-stage round in Apr 2023 drew 10 investors.

For fundraisers
Raising for a company like Prognos Health?

16 investors have backed Prognos Health.

See all 16 investors →

Frequently asked about Prognos Health

How much has Prognos Health raised?
Prognos Health has raised $66.5M in total across 2 recorded funding rounds.
When was Prognos Health's last funding round?
Prognos Health's most recent recorded round was Early Stage VC in Apr 2023, raising $23.3M.